These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 11448397

  • 1. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
    Harmon JV, Gruessner AC, Nakhleh RE, Zhang K, Gruessner RW.
    Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow augmentation in kidney transplantation: a large animal study.
    Gruessner RW, Zhang KY, Dunning M, Nakhleh RE, Gruessner AC.
    Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
    [Abstract] [Full Text] [Related]

  • 3. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation.
    Gruessner RW, Uckun FM, Pirenne J, Nakhleh RE, Benedetti E, Bekersky I, Troppmann C, Gruessner AC.
    Transplantation; 1997 Jan 15; 63(1):12-20. PubMed ID: 9000654
    [Abstract] [Full Text] [Related]

  • 4. Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study.
    Gruessner RW, Nakhleh RE, Harmon JV, Dunning M, Gruessner AC.
    Transplantation; 1998 Jul 27; 66(2):164-9. PubMed ID: 9701258
    [Abstract] [Full Text] [Related]

  • 5. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model.
    Pirenne J, Gruessner AC, Benedetti E, Troppmann C, Nakhleh RE, Uckun FM, Gruessner RW.
    Surgery; 1997 Jan 27; 121(1):79-88. PubMed ID: 9001555
    [Abstract] [Full Text] [Related]

  • 6. Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation.
    Gruessner RW, Levay-Young BK, Nakhleh RE, Shearer JD, Dunning M, Nelson CM, Gruessner AC.
    Transplantation; 2004 May 27; 77(10):1500-6. PubMed ID: 15239611
    [Abstract] [Full Text] [Related]

  • 7. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
    Pirenne J, Benedetti E, Gruessner A, Moon C, Hakim N, Fryer JP, Troppmann C, Nakhleh RE, Gruessner RW.
    Transplantation; 1996 Jun 27; 61(12):1685-94. PubMed ID: 8685944
    [Abstract] [Full Text] [Related]

  • 8. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation.
    Bakonyi Neto A, Ricordi C, Feo CF, Porcu A, Misiakos EP, Gandia C, Ruiz P, Bertho M, Carreno M, Esquenazi V, Miller J, Tzakis AG.
    Pediatr Transplant; 1999 Feb 27; 3(1):67-73. PubMed ID: 10359034
    [Abstract] [Full Text] [Related]

  • 9. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
    Mitsuoka N, Iwagaki H, Ozaki M, Sheng SD, Sadamori H, Matsukawa H, Morimoto Y, Matsuoka J, Tanaka N, Yagi T.
    Transpl Immunol; 2004 Nov 27; 13(3):155-60. PubMed ID: 15381197
    [Abstract] [Full Text] [Related]

  • 10. Quadruple immunosuppression in a pig model of small bowel transplantation.
    Gruessner RW, Fasola C, Fryer J, Nakhleh RE, Kim S, Gruessner AC, Beebe D, Moon C, Troppmann C, Najarian JS.
    J Surg Res; 1996 Feb 15; 61(1):260-6. PubMed ID: 8769976
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
    Gruessner RW, Fryer JP, Fasola C, Nakhleh RE, Gruessner AC, Kim S, Dunn DL, Pirenne J, Bekersky I, Benedetti E.
    Transplantation; 1995 Jan 27; 59(2):164-71. PubMed ID: 7530871
    [Abstract] [Full Text] [Related]

  • 12. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
    Levay-Young B, Gruessner SE, Shearer JD, Cheol Kim S, Nahkleh RE, Gruessner RW.
    J Surg Res; 2003 Sep 27; 114(1):78-89. PubMed ID: 13678702
    [Abstract] [Full Text] [Related]

  • 13. Combined liver-total bowel transplantation has no immunologic advantage over total bowel transplantation alone. A prospective study in a porcine model.
    Gruessner RW, Nakhleh RE, Benedetti E, Pirenne J, Belani KG, Beebe D, Carr R, Troppmann C, Gruessner AC.
    Arch Surg; 1997 Oct 27; 132(10):1077-85. PubMed ID: 9336505
    [Abstract] [Full Text] [Related]

  • 14. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.
    J Pediatr Surg; 2005 Jan 27; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 16. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.
    Barth RN, Nam AJ, Stanwix MG, Kukuruga D, Drachenberg CI, Bluebond-Langner R, Hui-Chou H, Shipley ST, Bartlett ST, Rodriguez ED.
    Transplantation; 2009 Dec 15; 88(11):1242-50. PubMed ID: 19996923
    [Abstract] [Full Text] [Related]

  • 17. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model.
    Bakonyi A, Berho M, Ruiz P, Misiakos EP, Carreno M, de Faria W, Sommariva A, Inverardi L, Miller J, Ricordi C, Tzakis AG.
    Transplantation; 2001 Sep 27; 72(6):983-8. PubMed ID: 11579288
    [Abstract] [Full Text] [Related]

  • 18. Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats.
    de Bruin RW, Saat RE, Heineman E, Jeekel J, Marquet RL.
    Transpl Int; 1993 Jan 27; 6(1):22-5. PubMed ID: 8452627
    [Abstract] [Full Text] [Related]

  • 19. Tolerogenic protocols for intestinal transplantation.
    Pirenne J, Kawai M.
    Transpl Immunol; 2004 Jan 27; 13(2):131-7. PubMed ID: 15380543
    [Abstract] [Full Text] [Related]

  • 20. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr 27; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.